Company Search:
Advanced Search
Sponsored Links
Nanocarrier Company Limited Company Snapshot
Nanocarrier Company Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nanocarrier Company Limited with three other companies in this sector in Japan: Onco Therapy Science, Inc (2016 sales of 266.90 million Japanese Yen [US$2.39 million] of which 100% was Research & Development In Medical), Oncolys Biopharma Inc (178.31 million Japanese Yen [US$1.60 million] ), and DNA Chip Research, Inc. (284.16 million Japanese Yen [US$2.54 million] ).

Sales Analysis. During the year ended March of 2016, sales at Nanocarrier Company Limited were ¥243.34 million (US$2.18 million). This is a sharp decrease of 64.0% versus 2015, when the company's sales were ¥675.80 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nanocarrier Company Limited
  Stock Performance Chart for Nanocarrier Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 779.00
(Figures in Japanese Yen)
1 Week -3.5%   13 Weeks -4.7%  
4 Weeks -18.3%   52 Weeks -29.8%  
Nanocarrier Company Limited Key Data:
  Ticker: 4571 Country: Japan
  Exchanges: FRA TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 243,344,000
(Year Ending Jan 2017).
Employees: 55
  Currency: Japanese Yen Market Cap: 33,632,824,882
  Fiscal Yr Ends: March Shares Outstanding: 43,174,358
  Share Type: Common Closely Held Shares: 6,453,800
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.